These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 34280733)

  • 1. Potential adverse effects of COVID19 vaccines among Iraqi population; a comparison between the three available vaccines in Iraq; a retrospective cross-sectional study.
    Almufty HB; Mohammed SA; Abdullah AM; Merza MA
    Diabetes Metab Syndr; 2021; 15(5):102207. PubMed ID: 34280733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of COVID-19 vaccination among healthcare workers in Iraq; adverse effects and hesitancy.
    Darweesh O; Khatab N; Kheder R; Mohammed T; Faraj T; Ali S; Ameen M; Kamal-Aldin A; Alswes M; Al-Jomah N
    PLoS One; 2022; 17(11):e0274526. PubMed ID: 36399454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Side effects after COVID-19 vaccinations among residents of Poland.
    Andrzejczak-Grządko S; Czudy Z; Donderska M
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(12):4418-4421. PubMed ID: 34227078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 Vaccination Reactogenicity in Persons With Multiple Sclerosis.
    Briggs FBS; Mateen FJ; Schmidt H; Currie KM; Siefers HM; Crouthamel S; Bebo BF; Fiol J; Racke MK; O'Connor KC; Kolaczkowski LG; Klein P; Loud S; McBurney RN
    Neurol Neuroimmunol Neuroinflamm; 2022 Jan; 9(1):. PubMed ID: 34753828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Antibody Levels Produced by Pfizer, AstraZeneca, and Sinopharm Vaccination in COVID-19 Patients in Erbil City-Iraq.
    Majed SO
    Cell Mol Biol (Noisy-le-grand); 2023 Mar; 69(3):103-112. PubMed ID: 37300682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 vaccination hesitancy among Iraqi general population between beliefs and barriers: An observational study.
    Shareef LG; Fawzi Al-Hussainy A; Majeed Hameed S
    F1000Res; 2022; 11():334. PubMed ID: 35529280
    [No Abstract]   [Full Text] [Related]  

  • 7. Reported COVID-19 vaccines side effects among Jordanian population: a cross sectional study.
    Omeish H; Najadat A; Al-Azzam S; Tarabin N; Abu Hameed A; Al-Gallab N; Abbas H; Rababah L; Rabadi M; Karasneh R; Aldeyab MA
    Hum Vaccin Immunother; 2022 Dec; 18(1):1981086. PubMed ID: 34614383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Side effects of Pfizer/BioNTech (BNT162b2) COVID-19 vaccine reported by the Birzeit University community.
    Abukhalil AD; Shatat SS; Abushehadeh RR; Al-Shami N; Naseef HA; Rabba A
    BMC Infect Dis; 2023 Jan; 23(1):5. PubMed ID: 36604613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Side-effects of COVID-19 vaccines among the Saudi population: A cross-sectional study.
    Almughais ES; Alharbi AH; Aldarwish HA; Alshammari AF; Alsuhaymi RS; Almuaili JA; Alanizy AM
    Saudi Med J; 2022 Apr; 43(4):386-393. PubMed ID: 35414617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine Side Effects Following COVID-19 Vaccination Among the Residents of the UAE-An Observational Study.
    Ganesan S; Al Ketbi LMB; Al Kaabi N; Al Mansoori M; Al Maskari NN; Al Shamsi MS; Alderei AS; El Eissaee HN; Al Ketbi RM; Al Shamsi NS; Saleh KM; Al Blooshi AF; Cantarutti FM; Warren K; Ahamed F; Zaher W
    Front Public Health; 2022; 10():876336. PubMed ID: 35602146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of COVID-19 vaccines.
    Al Khames Aga QA; Alkhaffaf WH; Hatem TH; Nassir KF; Batineh Y; Dahham AT; Shaban D; Al Khames Aga LA; Agha MYR; Traqchi M
    J Med Virol; 2021 Dec; 93(12):6588-6594. PubMed ID: 34270094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are some COVID-19 vaccines better than others regarding the short-term side effects?
    Al-Zidan R; Darweesh O; Salah M; Bebane P; Ahmed H; Abdulrazzaq G; Shanshal S; Alomari N
    Ceska Slov Farm; 2023; 72(1):45-54. PubMed ID: 36858979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Which Type of the Promising COVID-19 Vaccines Produces Minimal Adverse Effects? A Retrospective Cross-Sectional Study.
    Attash HM; Al-Obaidy LM; Al-Qazaz HK
    Vaccines (Basel); 2022 Jan; 10(2):. PubMed ID: 35214647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG level of the third booster dose for mRNA of SARS-CoV-2 vaccines among Iraqi healthcare workers.
    Rasheed WS; Sarkees AN
    Medicine (Baltimore); 2023 Oct; 102(40):e35444. PubMed ID: 37800839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse events following administration of COVID-19 vaccines in Saudi Arabia.
    Alqahtani S; Jokhdar H; Al-Tawfiq JA; Al-Otaibi S; Assiri A; Almudarra S; Alabdulkareem K; Haji A
    Sci Rep; 2022 Nov; 12(1):19551. PubMed ID: 36379996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID19 vaccination choice among Iraqi students at Al-Zahraa University for women.
    Hadi Al Kazzaz H
    F1000Res; 2021; 10():1015. PubMed ID: 35903215
    [No Abstract]   [Full Text] [Related]  

  • 19. EVALUATION OF COVID-19 VACCINES EFFICACY IN IRAQI PEOPLES.
    Jawad MJ; Jawad MJ; Hasan IS; Hassan SM; Fatima G; Hadi NR
    Wiad Lek; 2022; 75(4 pt 2):929-937. PubMed ID: 35633320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative SARS-CoV-2 anti-spike responses to Pfizer-BioNTech and Oxford-AstraZeneca vaccines by previous infection status.
    Eyre DW; Lumley SF; Wei J; Cox S; James T; Justice A; Jesuthasan G; O'Donnell D; Howarth A; Hatch SB; Marsden BD; Jones EY; Stuart DI; Ebner D; Hoosdally S; Crook DW; Peto TEA; Walker TM; Stoesser NE; Matthews PC; Pouwels KB; Walker AS; Jeffery K
    Clin Microbiol Infect; 2021 Oct; 27(10):1516.e7-1516.e14. PubMed ID: 34111577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.